Clinical trials
Young Adults clinical trials
Below are recruiting young adults clinical trials, each written for real people, not researchers. We’re tracking 345 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07651163Enrolling by invitationPhase 2/Phase 3
Comparing three chemotherapy regimens for newly diagnosed blood cancer
This trial tests three different chemotherapy regimens for adults 15–65 years old with newly diagnosed acute myeloid leukemia (AML)—a serious blood cancer. The goal is to see which treatment approach works best for patients with intermediate or high-risk disease who are fit enough for intensive chemotherapy.
Hangzhou, ZhejiangAges 15–65 - NCT07638345Recruiting
AI-powered weight management for teens with diabetes or asthma
This study tests a smartphone app that uses artificial intelligence to help families manage weight and health for teenagers (ages 12–21) with Type 1 Diabetes or asthma. The app is designed to be personalized to each family's needs and may help improve overall health outcomes.
SevilleAges 18 years+ - NCT07645443Recruiting
Mindfulness group therapy for young adults with early psychosis
This study tests whether a mindfulness-based group therapy program helps young adults who have recently experienced their first psychotic episode. You would participate in group sessions alongside your regular treatment to see if mindfulness can improve how you feel.
Mannheim, Baden-WurttembergAges 16–35 - NCT07631663Recruiting
How Okra Flour Biscuits Affect Fullness and Appetite
This study tests whether biscuits made with okra flour help people feel fuller longer. Researchers want to understand how this food affects appetite and satiety (the feeling of fullness) in healthy young adults.
Serdang, SelangorAges 18–39 - NCT06698341Recruiting
Studying heart attacks in young adults to understand new genes
This trial looks for new genetic causes of heart attacks in young adults. If you had a heart attack at a young age and are of Chinese, Malay, or Indian descent, this study may help find answers.
SingaporeAges 21–60 - NCT07616934RecruitingPhase 1
Safety and immune response study of VAX-A1 vaccine in healthy young adults
This study tests a new vaccine called VAX-A1 in healthy people aged 18–40 to see if it's safe and if it helps the body build protection against Group A Streptococcus (a bacteria that can cause serious infections). You'll receive two vaccine doses and have blood tests and heart monitoring over 6 months.
Adelaide, South AustraliaAges 18–40 - NCT07607639Recruiting
Gum Health Markers in Children and Young Adults
This study looks at special proteins in the fluid around your gums to understand how gum disease develops in young people. By studying these markers, researchers hope to better understand and treat gum inflammation.
NiğdeAges 8–24 - NCT06715267Recruiting
MPN in youth: studying disease features and complications
This study looks at young people (children, teens, and adults under 30) who have a type of blood cancer called myeloproliferative neoplasm (MPN). It aims to better understand the disease and its complications over time, with the goal of improving care.
BrestAges birth–30 years - NCT06357442Recruiting
Comparing progesterone methods for young people on estrogen therapy
This study compares two ways to give progesterone to young people on estrogen replacement therapy to see how they affect the lining of the uterus. It will help find which approach may be safer and more effective for your health.
Aurora, ColoradoAges 12–25 - NCT05620849Recruiting
Young adult alcohol health education program study
This study tests an education program about alcohol and health for young adults. It may help you learn safer choices and better understand health effects.
Seattle, WashingtonAges 18–24 - NCT07573111RecruitingPhase 1
QUAIL-100 for Children With Blood Cancers After Stem Cell Transplant
This study tests a new experimental treatment called QUAIL-100 in children and young adults who have had a stem cell transplant for a serious blood cancer. The treatment is designed to help the immune system fight remaining cancer cells.
Palo Alto, CaliforniaAges 1.5 years–39 years - NCT05275881Recruiting
Virtual reality during procedures for young blood or cancer patients
This trial tests whether using virtual reality (VR) during certain procedures can make them easier for children, teens, and young adults with blood or cancer-related conditions. Participants must be able to safely use a VR headset and be willing to take part.
PoitiersAges 7–24 - NCT07565129Recruiting
Mixed Reality Therapy for Eating Disorder Risk in Teens and Young Adults
This study tests a new virtual-reality based therapy called Dialectical Behavioral Therapy (DBT)—which teaches skills to manage difficult emotions—to help teenagers and young adults who show early warning signs of eating disorders. The goal is to prevent eating disorders from developing by improving how you handle emotions.
Barcelona, BarcelonaAges 13–35 - NCT07560826RecruitingPhase 2
Study of newly diagnosed bone cancer treatment and biology
This research study follows young people newly diagnosed with osteosarcoma (a type of bone cancer) who are receiving standard chemotherapy. Researchers will collect information about how the cancer responds to treatment and study biological samples to better understand the disease.
Chapel Hill, North CarolinaAges 7–22 - NCT07566377RecruitingPhase 2
Cord Blood Transplant for Children and Young Adults With Blood Cancer
This study tests whether using cord blood stem cells (collected from umbilical cords after birth) can help treat high-risk blood cancers in children and young adults when a matched donor is not quickly available. Cord blood transplants may help prevent cancer from coming back.
New York, New YorkAges Up to 26 years - NCT04861818Recruiting
Testing how exercise timing affects memory in healthy young adults
This study looks at whether the time of day you exercise changes how well you remember things. It asks healthy young adults to do controlled exercise over two lab visits and avoids exercise for a few days to compare results.
Greensboro, North CarolinaAges 18–25 - NCT07551583RecruitingPhase 2
Nivolumab plus chemotherapy for early-stage Hodgkin lymphoma in young people
This study tests a combination of a newer immunotherapy drug (nivolumab) with standard chemotherapy (AVD) in children, teens, and young adults with newly diagnosed, early-stage Hodgkin lymphoma—a blood cancer affecting lymph nodes. The goal is to see if adding immunotherapy improves outcomes while being tolerable for this age group.
Houston, TexasAges 2–21 - NCT07547176Recruiting
How Your Body Uses Protein From Beef
This study measures how your body breaks down and uses protein from beef at different amounts. Researchers want to understand the best dose of beef protein for young, healthy adults.
Maastricht, LimburgAges 18–35 - NCT07543653Recruiting
Testing ways to reduce loneliness in young Chinese adults
This study tests different approaches to help young adults (ages 18–30) who feel lonely. Researchers want to see which methods work best to help people feel more connected.
Hong Kong, Hong KongAges 18–30 - NCT06756152RecruitingPhase 2/Phase 3
Preventing GVHD after transplant for blood cancers in children and young adults
This trial tests a combination of four medicines (cyclophosphamide, abatacept, vedolizumab, and ruxolitinib) to prevent graft-versus-host disease (GVHD) after a stem cell transplant for children and young adults with certain blood cancers. The goal is to see if this approach reduces the risk of GVHD, a serious complication where donor cells attack the body.
MoscowAges 1 day–21 years - NCT07527624Recruiting
Study of work and social inclusion for young adults with rare genetic conditions
This study looks at how young adults aged 15–25 with rare genetic conditions (like certain bone, skin, hearing, or facial conditions) are doing in school, work, and social life. Researchers want to understand what helps or prevents young people with these conditions from being included in their communities.
Paris, Île-de-France RegionAges 15–25 - NCT05922462Recruiting
Greek yogurt study in young athletes
This study tests whether eating more Greek yogurt affects health in youth and young adult athletes. It may help researchers understand benefits and safety for active people.
St. Catharines, OntarioAges 15–22 - NCT07516873Recruiting
Mindfulness and Nerve Stimulation for Young Adults Drinking Heavily
This study tests whether brief mindfulness training combined with a mild electrical stimulation device on the ear can help reduce cravings and urges to drink alcohol in people aged 21–29 who drink heavily. The goal is to understand if this combination approach works better than either alone.
Malden, MassachusettsAges 21–29 - NCT07521371Enrolling by invitation
Intranasal Insulin for Autism in Children and Young Adults
This study observes how intranasal insulin (a form of insulin delivered through the nose) affects children and young adults with autism spectrum disorder who are already using or planning to use it as part of their regular care. Researchers will track changes in behavior and social skills over about 6 months.
Spring, TexasAges 4–21
Hear when a new Young Adults trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for young adults?
- Yes. Clin2 currently lists 345 recruiting young adults studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a young adults trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a young adults trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.